针对性治疗,化疗及其组合治疗晚期胆管癌的比较疗效:系统性审查和网络元分析
Zhoujun Liao1, Zhuoyue Yao2, Zhiqing Yang3
1Department of General Surgery, Panzhihua College Affiliated Hospital, Panzhihua University, Panzhihua, Panzhihua, China.
PeerJ
|May 19, 2025
概括
对于晚期胆管癌,化学疗法和向治疗联合 (TT+CT) 与安慰剂相比,显著改善整体存活率 (OS) 和无进展存活率 (PFS). 单独的向治疗也可以改善PFS,提高患者的生活质量.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
- 临床试验 临床试验
背景情况:
- 胆管癌是一种具有有限治疗选择的侵袭性癌症.
- 现有的随机对照试验 (RCT) 对各种疗法显示了相互矛盾的结果.
- 本研究解决了对综合有效性评估的需求.
研究的目的:
- 评估化疗 (CT),向疗法 (TT) 和结合疗法 (TT+CT) 对晚期胆管癌的疗效.
- 进行有关随机对照试验的系统审查和网络元分析.
- 将治疗结果与安慰剂和不同治疗策略进行比较.
主要方法:
- 搜索了主要的数据库 (PubMed,EmBase,Medline,Cochrane) 进行RCT.
- 包括比较CT,TT,TT+CT与安慰剂的研究.
- 提取了总生存时间 (OS) 和无进展生存时间 (PFS) 的数据.
主要成果:
- 分析了13个涉及1914名患者的RCT.
- 所有治疗组 (CT,TT,TT+CT) 与安慰剂相比,显示出显著的OS和PFS改善.
- 与单独CT或TT相比,组合疗法 (TT+CT) 显示出优异的OS和PFS结果.
结论:
- 化疗,向疗法和组合疗法为晚期胆管癌提供了显著的生存益处.
- 组合疗法 (TT+CT) 在OS和PFS中提供了最实质性的改善.
- 单独针对性治疗可显著增强PFS,有助于改善患者的生活质量.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...